Neuroscientist Andrew Huberman Forced To Deny Conflict of Interest After Sudden Increased Interest Into Peptides
Stanford neuroscientist Andrew Huberman found himself on the defensive this week after a wave of audience skepticism followed his increasingly enthusiastic public commentary on peptides, forcing him to issue multiple denials of any financial ties to the pharma or peptide industries. The clarifications came after a noticeable shift in Huberman’s tone on the subject prompted … Read more